Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Neurology | Family Medicine
Brain Tumor Clinical Trials
A listing of Brain Tumor medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arkansas
Little Rock : University of Arkansas for Medical Sciences
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
California
Duarte : City of Hope
COG ANBL0032: Phase III Randomized Study Of Chimeric Antibody 14.18 (CH14.18) In High Risk Neuroblastoma Following Myeloablative Therapy And Autologous Stem Cell Rescue
View More »
Duarte : City of Hope
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Irvine : UCI Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
La Jolla : UCSD Moores Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Los Angeles : UCLA
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Newport Beach : Hoag Memorial Hospital Presbyterian
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Sacramento : Sutter Institute for Medical Research
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
South Pasadena : South Pasadena Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Colorado
Aurora : University of Colorado Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
District of Columbia
Washington : Georgetown University Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Florida
Miami Beach : Mount Sinai CCOP
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Illinois
Chicago : Rush University Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Chicago : University of Illinois Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Peoria : Illinois Cancer Care
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Indiana
Indianapolis : IU Simon Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Massachusetts
Boston : Tufts Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Michigan
Ann Arbor : University of Michigan, Department of Neurosurgery
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Detroit : Henry Ford Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Minnesota
Minneapolis : Virginia Piper Cancer Institute
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Missouri
Kansas City : St. Luke's Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
St. Louis : Washington University School of Medicine
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New Jersey
Hackensack : John Theurer Cancer Center at Hackensack University Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Summit : Overlook Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York
Commack, Great Neck : Long Island Brain Tumor Centre at Neurological Surgery P.C.
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Huntington : Huntington Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Manhasset : North Shore University Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Mineola : Winthrop University Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : Columbia University Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
View More »
New York : New York University Clinical Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Oceanside : South Nassau Community Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rochester : University of Rochester Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rockville Centre : Mercy Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
North Carolina
Chapel Hill : University of North Carolina
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Ohio
Cincinnati : UC Cancer Institute
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : Cleveland Clinic Foundation
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : University Hospitals of Cleveland
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rhode Island
Providence : Rhode Island Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
South Carolina
Tennessee
Nashville : St. Thomas Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Nashville : Vanderbilt Ingram Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Texas
Dallas : Baylor Research Institute
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Washington
Seattle : Swedish Hospital Neuroscience Research
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
